Grants and Contributions:
Title:
Branding Strategy for the Probiotics for the Prevention and Treatment of the Upper Respiratory Tract and Dental/Oral Infections
Agreement Number:
955863
Agreement Value:
$35,000.00
Agreement Date:
Aug 1, 2020 - Mar 31, 2021
Description:
The project aims to develop branding strategy for novel proprietary probiotics, scientifically proven to inhibit major pathogens responsible for the infections of the upper respiratory tract and dental/oral infections, in order to support international commercialization via multiple channels.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
London, Ontario, CA N6G 1L7
Reference Number:
172-2020-2021-Q2-955863
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807143417
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Amendment Date
Feb 28, 2021
Recipient's Legal Name:
Stellar Biome Inc.
Federal Riding Name:
London North Centre
Federal Riding Number:
35052
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: